Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
62
Frequently Asked Questions
What is Market Cap of Enliven Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Enliven Therapeutics Inc market cap is $1.19B.
What is the 52-week high for Enliven Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Enliven Therapeutics Inc 52 week high is $30.03 as of September 06, 2025.
What is the 52-week low for Enliven Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Enliven Therapeutics Inc 52 week low is $13.30 as of September 06, 2025.
What is Enliven Therapeutics Inc stock price today?
Enliven Therapeutics Inc stock price today is $20.15.
What was Enliven Therapeutics Inc stock price yesterday?
Enliven Therapeutics Inc stock price yesterday was $20.01.
What is the PE ratio of Enliven Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Enliven Therapeutics Inc’s P/E ratio is -10.00.
What is the Price-to-Book ratio of Enliven Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Enliven Therapeutics Inc P/B ratio is 2.4262.
What is the 50-day moving average of Enliven Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Enliven Therapeutics Inc 50-day moving average is $20.45.
How many employess does Enliven Therapeutics Inc has?